Insurers Receive Orders to Cover Coronavirus Antibody Tests

With the Trump administration anxious to “reopen” the U.S. economy and ease the social-distancing measures meant to slow the spread of COVID-19, officials have pointed to antibody testing as a critical tool to accomplish those goals. To that end, the administration on April 11 issued a document clarifying that most private health plans must cover such tests, which detect antibodies against the new coronavirus found in the blood of people who have been infected and now may be immune.

Experts tell AIS Health that the requirement to cover antibody (also known as serological) testing wasn’t entirely unexpected, but it does raise a host of still- unanswered questions, such as how much these tests will cost, how widely available they’ll be, and whether they can be relied upon.

0 Comments
© 2023 MMIT
Leslie Small

Leslie Small

Leslie has been reporting and editing in various journalism roles for nearly a decade. Most recently, she was the senior editor of FierceHealthPayer, an e-newsletter covering the health insurance industry. A graduate of Penn State University, she previously served in editing roles at newspapers in Pennsylvania, Virginia and Colorado.

Related Posts

businessman-viewing-news-update-journalism-headline-on-a-laptop
January 27

News Briefs: ACA Marketplace Enrollment Tops 16.3M

READ MORE
capitol-hill
January 27

Even With Split Congress, Some Experts Predict Heightened Health Care Oversight

READ MORE
wall-street-logo
January 27

Elevance Sees Double-Digit Percentage EPS Growth for Fifth Consecutive Year

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today